Loading quotes...
Forecast
| Buy |
5 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
Bio-Path Holdings moves headquarters to Wyoming and creates Series S preferred shares
Bio-Path Holdings approved the move of its headquarters to Wyoming and filed an amendment to its charter to create a new class of Series S preferred shares consisting of 51 shares, each convertible into one common share and representing 1% of diluted voting power. The company also appointed Wendy M. Charles and Michael Hickey to a newly formed scientific advisory board; both received three-year contracts and were granted 100,000 stock options each with an exercise price of $0.06. The information comes from a filing with the SEC. » More on de.investing.com
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | 100.00% |
| Net profit | -2.31M | 40.78% |
| EBITDA | -821.01K | 78.60% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €147.93K |
Number of shares | 9.34M |
52-week high/low | €0.11 - €0.00861 |
| Dividends | No |
Beta | -0.50 |
P/E ratio | -0.07 |
PEG ratio | 0.00 |
P/B ratio | -0.06 |
P/S ratio | 0.00 |
Company profile
| Name | BIO-PATH HLDGS IN.DL-,001 Aktie |
| CEO | Vikram Paul Grover |
| Employees | 1 |
Discover assets
Shareholders of BIO-PATH HLDGS IN.DL-,001 Aktie also invest in the following assets



